"Using Zika Virus to Target Deadly Cancers"
Researchers in Florida are exploring the potential of using the Zika virus as a therapy for neuroblastoma, a deadly childhood cancer, by targeting the CD24 protein that is overexpressed in these tumors. In a study on mice, the virus led to significant reduction and even complete elimination of neuroblastoma tumors. While this approach shows promise, further studies are needed to ensure its safety before moving on to clinical trials. Zika virus, typically spread by mosquitoes and through unprotected sex, has shown potential to be an effective bridge therapy for high-risk neuroblastoma patients and possibly for other cancers expressing high levels of CD24.